Skip to content

Randomised trial, 2016

Does blocking progesterone conversion help PMDD symptoms?

A high dose of dutasteride reduced several PMDD symptoms by blocking conversion of progesterone to a hormone compound. However, only the high dose worked and the study was small.

Early or limited evidence 16 women with PMDD and 16 control women

What they did

Randomized double-blind placebo-controlled crossover trial where 16 women with PMDD and 16 control women took either placebo or dutasteride for three menstrual cycles. Low-dose group received 0.5 mg daily and high-dose group received 2.5 mg daily. Researchers measured symptoms and hormone levels at two phases of the cycle.

What they found

The low-dose dutasteride had no significant effect and hormone levels still changed across the cycle as usual. The high-dose group had statistically significant reductions in irritability, sadness, anxiety, food cravings, and bloating compared to placebo. Dutasteride did not affect mood in the control women.

What it means for you

High-dose dutasteride may work by stabilizing hormone levels related to mood, but only the high dose was effective. The study was very small (16 women per group) and used a complex crossover design, so larger studies are needed to confirm.

2.5 mg/day

effective high dose

0.5 mg/day

low dose (not effective)

3

menstrual cycles

About the study

Original title
5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
Authors
Martinez PE, Rubinow DR, Nieman LK et al.
Journal
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Year
2016
Study design
Randomised trial
Participants
16
What was tested
Dutasteride at low dose (0.5 mg daily) or high dose (2.5 mg daily)
Open access
Yes

Topics